LFWD
Price
$1.76
Change
-$0.08 (-4.35%)
Updated
Feb 21 closing price
Capitalization
44.44M
80 days until earnings call
PEN
Price
$291.68
Change
-$11.44 (-3.77%)
Updated
Feb 21 closing price
Capitalization
8.64B
72 days until earnings call
Ad is loading...

LFWD vs PEN

Header iconLFWD vs PEN Comparison
Open Charts LFWD vs PENBanner chart's image
Lifeward
Price$1.76
Change-$0.08 (-4.35%)
Volume$336.27K
Capitalization44.44M
Penumbra
Price$291.68
Change-$11.44 (-3.77%)
Volume$635.33K
Capitalization8.64B
LFWD vs PEN Comparison Chart
Loading...
LFWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFWD vs. PEN commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFWD is a Hold and PEN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (LFWD: $1.76 vs. PEN: $291.68)
Brand notoriety: LFWD and PEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LFWD: 31% vs. PEN: 130%
Market capitalization -- LFWD: $44.44M vs. PEN: $8.64B
LFWD [@Medical Specialties] is valued at $44.44M. PEN’s [@Medical Specialties] market capitalization is $8.64B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFWD’s FA Score shows that 1 FA rating(s) are green whilePEN’s FA Score has 1 green FA rating(s).

  • LFWD’s FA Score: 1 green, 4 red.
  • PEN’s FA Score: 1 green, 4 red.
According to our system of comparison, PEN is a better buy in the long-term than LFWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFWD’s TA Score shows that 6 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • LFWD’s TA Score: 6 bullish, 4 bearish.
  • PEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LFWD is a better buy in the short-term than PEN.

Price Growth

LFWD (@Medical Specialties) experienced а -19.22% price change this week, while PEN (@Medical Specialties) price change was +8.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

LFWD is expected to report earnings on May 13, 2025.

PEN is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEN($8.64B) has a higher market cap than LFWD($44.4M). PEN YTD gains are higher at: 22.823 vs. LFWD (2.023). PEN has higher annual earnings (EBITDA): 109M vs. LFWD (-21.77M). PEN has more cash in the bank: 289M vs. LFWD (28.1M). LFWD has less debt than PEN: LFWD (1.9M) vs PEN (234M). PEN has higher revenues than LFWD: PEN (1.06B) vs LFWD (13.9M).
LFWDPENLFWD / PEN
Capitalization44.4M8.64B1%
EBITDA-21.77M109M-20%
Gain YTD2.02322.8239%
P/E RatioN/A93.70-
Revenue13.9M1.06B1%
Total Cash28.1M289M10%
Total Debt1.9M234M1%
FUNDAMENTALS RATINGS
LFWD vs PEN: Fundamental Ratings
LFWD
PEN
OUTLOOK RATING
1..100
3067
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10050
SMR RATING
1..100
9685
PRICE GROWTH RATING
1..100
6440
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LFWD's Valuation (25) in the Medical Specialties industry is significantly better than the same rating for PEN (100). This means that LFWD’s stock grew significantly faster than PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (50) in the Medical Specialties industry is somewhat better than the same rating for LFWD (100). This means that PEN’s stock grew somewhat faster than LFWD’s over the last 12 months.

PEN's SMR Rating (85) in the Medical Specialties industry is in the same range as LFWD (96). This means that PEN’s stock grew similarly to LFWD’s over the last 12 months.

PEN's Price Growth Rating (40) in the Medical Specialties industry is in the same range as LFWD (64). This means that PEN’s stock grew similarly to LFWD’s over the last 12 months.

PEN's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for LFWD (100). This means that PEN’s stock grew significantly faster than LFWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFWDPEN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
LFWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HSUN34.870.04
+0.13%
Hartford Strategic Income ETF
FEUZ44.27-0.39
-0.87%
First Trust Eurozone AlphaDEX® ETF
GSLC117.84-1.97
-1.64%
Goldman Sachs ActiveBeta® US LgCp Eq ETF
XMVM55.38-1.19
-2.10%
Invesco S&P MidCap Value with Momt ETF
XNTK219.59-5.64
-2.50%
SPDR® NYSE Technology ETF

LFWD and

Correlation & Price change

A.I.dvisor tells us that LFWD and PEN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFWD and PEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFWD
1D Price
Change %
LFWD100%
-4.08%
PEN - LFWD
32%
Poorly correlated
-3.77%
POAI - LFWD
28%
Poorly correlated
-1.36%
MASS - LFWD
28%
Poorly correlated
-6.99%
AVNS - LFWD
26%
Poorly correlated
-0.19%
BMRA - LFWD
25%
Poorly correlated
-5.73%
More

PEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with QDEL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-3.77%
QDEL - PEN
34%
Loosely correlated
-1.39%
SNN - PEN
31%
Poorly correlated
+1.59%
ICCM - PEN
31%
Poorly correlated
-6.00%
BIO - PEN
31%
Poorly correlated
-1.94%
NVST - PEN
30%
Poorly correlated
-2.70%
More